Walmart’s Bold AI Overhaul Could Drive Efficiency, Margins And Market Edge
Walmart streamlines AI strategy with four ‘super agents’ for customers, employees, engineers & suppliers. Uses open-source standard to communicate. read more
Read More
HCA Healthcare Eyes $76 Billion Revenue, Aggressive Profit Growth
HCA Healthcare beat Q2 expectations and raised its 2025 earnings and sales guidance amid revenue growth and improved operating margins. read more
MARA Holdings Stock Slips On $1 Billion Note Offering, Analyst Upgrade Offers Support
Shares of MARA Holdings Inc (NASDAQ:MARA) are trading lower Friday, falling nearly 3% after the Bitcoin (CRYPTO: BTC) mining giant this week announced a significant capital raise. read more
Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results
Latest Ratings for EW Date Firm Action From To Feb 2022 UBS Upgrades Neutral Buy Jan 2022 Morgan Stanley Maintains Overweight Jan 2022 Raymond James Maintains Outperform View More Analyst Ratings for EW View the Latest Analyst Ratings read more
XRP Stuck Around $3.10: Is The Rally Already Over?
Despite XRP’s (CRYPTO: XRP) recent price cooldown, market commentators remain optimistic about XRP, boosted by growth in Ripple’s ecosystem. read more
These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings
Latest Ratings for LH Date Firm Action From To Feb 2022 Morgan Stanley Maintains Overweight Feb 2022 Credit Suisse Maintains Outperform Jan 2022 Deutsche Bank Downgrades Buy Hold View More Analyst Ratings for LH View the Latest Analyst Ratings read more
Dow Analysts Slash Their Forecasts After Weak Q2 Results
Latest Ratings for DOW Date Firm Action From To Jan 2022 Goldman Sachs Maintains Neutral Jan 2022 Goldman Sachs Maintains Neutral Jan 2022 Mizuho Maintains Neutral View More Analyst Ratings for DOW View the Latest Analyst Ratings read more
Carter’s Investors Fret As Tariff Uncertainty Clouds Retailer’s Future
Carter’s stock slips after weak earnings and tariff risks prompt fiscal 2025 guidance suspension. read more
Imax Analysts Increase Their Forecasts After Q2 Results
Latest Ratings for IMAX Date Firm Action From To Oct 2021 Wells Fargo Initiates Coverage On Overweight Jun 2021 Goldman Sachs Downgrades Neutral Sell Apr 2021 Wedbush Upgrades Neutral Outperform View More Analyst Ratings for IMAX View the Latest Analyst Ratings read more